United States Department of Veterans Affairs
United States Department of Veterans Affairs
National Hepatitis C Program
Providers' Home > Hepatitis C Topics > TreatmentEnlarge Text Size:Small Font SizeMedium Font SizeLarge Font Size

Hepatitis C Topics

Treatment

Contents
VA Policies & Notifications
Guidelines
Clinical Manual
Conference Presentations
Clinician Tools
Case Studies
Journal Articles
Patient Education
Related Resources

VA Policies & Notifications

bulletVHA Informed Consent For Clinical Treatments and Procedures, Under Secretary for Health
VHA Handbook 1004.1, January 29, 2003; Intranet only
bulletVA National Formulary Process
Directive 2001-044, July 24, 2001

Guidelines

bulletManagement and Treatment of Hepatitis C Viral Infection: Recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office
Hepatitis C treatment recommendations, October 2006
bulletHepatitis C Treatment-Related Anemia & Neutropenia
Criteria for Use documents for using granulocyte stimulating colony factor and recombinant erythropoietin for hepatitis C treatment-related anemia
bulletRecommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease
Morbidity and Mortality Weekly Report: Recommendations and Reports, October 16, 1998

Clinical Manual

bulletHepatitis C Treatment
Practical information for providers about hepatitis C treatment, including the Patient Treatment Tracking Chart
bulletInterferon and Ribavirin Treatment Side Effects
Discussion of treatment side effects and ways to manage symptoms
bulletPharmaceutical Options for Managing Viral Hepatitis and Cirrhosis Complications in the VA Health Care System
List of pharmaceutical options within the VA Health Care System for hepatitis B, hepatitis C, treatment side effects, cirrhosis management, and prevention

Conference Presentations

bullet2004 Advanced Liver Disease Training Program
April 12-14, 2004, New York City

Clinician Tools

bulletHepatitis C Quicknotes
Abbreviated version of the most recent VA Hepatitis C Treatment Recommendations (October 2006)

Case Studies

bulletAdvanced Liver Disease Case Studies
These cases illustrate a number of areas that are actively being researched.

Journal Articles

bulletJournal Articles on Treatment

Patient Education

bulletQuestions to Ask Your Doctor about Treatment
A one-page printable sheet of questions that patients can ask their doctors about treatment
bulletPatient Treatment Tracking Chart
Blank chart where patients can record dates of blood work, laboratory values, hepatitis C viral load levels, medication dosages, and side effects
bulletTreatment Side Effects Chart
A one-page printable sheet of tips for coping with common side effects of hepatitis C treatment
bulletTreatment for Hepatitis C
Video & transcript
bulletHepatitis C Education Class
Slide set & script
bulletPatient Education Brochures
A variety of PDF brochures on living with hepatitis C
bulletPatient Education Wallet Cards
Easy-to-carry cards with tips on living with hepatitis C
Related Resources
The appearance of external hyperlinks does not constitute endorsement by the Department of Veterans Affairs of the linked Web sites, or the information, products or services contained therein.
Ribavirin Pregnancy Registry
In the event that pregnancy occurs either in the patient or in the partner receiving ribavirin, ribavirin should be immediately discontinued and the pregnancy should be reported to the Ribavirin Pregnancy Registry at 1-800-593-2214 or www.ribavirinpregnancyregistry.com.
Adherence and Compliance
Alternative & Complementary Medicine
Clinical Research & Trials
Drug Information
Global Treatment Access
Pharmaceutical & Biotechnology Companies
iconEmail this page

Hepatitis C is a part of the Office of Public Health and Environmental Hazards.

OPHEH | Environmental Agents | Emergency Management | Public Health
Occupational Health | Women's Health | Environmental Epidemiology